RAS mutation and associated risk of malignancy in the thyroid gland: An FNA study with cytology-histology correlation.

This study demonstrated that the overall RAS mutation-associated ROM in thyroid FNA was intermediate (29%), and isolated HRAS mutations appeared to have a higher ROM (27%) than NRAS and KRAS mutations (15% and 14%, respectively).